Nuvectis Pharma Inc is a biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
NVCT is expected to report earnings to fall 5.38% to -24 cents per share on November 10
Q3'26
Est.
$-0.25
Q1'26
Beat
by $0.05
Q4'25
Missed
by $0.06
Q3'25
Missed
by $0.19
Q2'25
Missed
by $0.05
The last earnings report on May 05 showed earnings per share of -25 cents, beating the estimate of -31 cents. With 111.69K shares outstanding, the current market capitalization sits at 768.39M.